{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:13Z","timestamp":1792788073819,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NIA","award":["U54AG054345"],"award-info":[{"award-number":["U54AG054345"]}]},{"name":"NIH\/NIA","award":["1RF1AG055104"],"award-info":[{"award-number":["1RF1AG055104"]}]},{"name":"NIH\/NIA","award":["U19AG069701"],"award-info":[{"award-number":["U19AG069701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Humanized\n                      <jats:italic>APOE<\/jats:italic>\n                      targeted-replacement (TR) mice are essential tools for studying apoE isoform effects in Alzheimer\u2019s disease (AD) and other apoE-related disorders. Despite their widespread use, existing\n                      <jats:italic>APOE<\/jats:italic>\n                      mouse models, generated with different gene targeting strategies, have not been directly compared in terms of apoE isoform expression, lipid profiles, and transcriptomic signatures. Such differences could impact how we interpret\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype-related outcomes, as well as related underlying molecular mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a comprehensive molecular comparison of humanized\n                      <jats:italic>APOE<\/jats:italic>\n                      mouse models from three sources: Taconic Biosciences (TAC), the Cure Alzheimer\u2019s Fund (CAF), and The Jackson Laboratory (JAX). We assessed apoE protein and transcript levels, peripheral plasma lipid composition, and bulk brain transcriptomics. ApoE isoform levels were evaluated by biochemical and proteomic measurements. Peripheral lipids, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), cholesterol, and triglycerides, were also measured. We employed complementary bioinformatics analyses to evaluate brain transcriptomes and identify differentially expressed genes (DEGs) and networks based on source,\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype, and sex.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that apoE isoforms exhibited differential levels among the three sources in the brain, liver, and plasma. Peripheral lipoproteins and lipids, including LDL, HDL, cholesterol, and triglycerides, also showed distinct concentrations in each source and genotype. Importantly, we identified distinct brain transcriptional signatures among these mouse models, which were influenced by source,\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype, and sex. Finally, our analysis revealed specific differentially expressed genes and pathways impacted by source, genotype, and sex.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings highlight\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype- and source-dependent variations in apoE isoform levels, lipid profiles, and molecular pathways. This study underscores the importance of consistency and caution in choosing and utilizing humanized\n                      <jats:italic>APOE<\/jats:italic>\n                      mouse models, offering molecular insights into key apoE-related outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-026-00940-6","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:15:09Z","timestamp":1774325709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular characterization of humanized APOE mouse models reveals source and genotype dependent differences"],"prefix":"10.1186","volume":"21","author":[{"given":"Na","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Alnobani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suren","family":"Jeevaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"McReynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Wren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi C.","family":"Ikezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka A.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sasner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"940_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0021-9150(94)05402-5","volume":"112","author":"CS Hanlon","year":"1995","unstructured":"Hanlon CS, Rubinsztein DC. Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis. 1995;112:85\u201390.","journal-title":"Atherosclerosis"},{"key":"940_CR2","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions. Proc Natl Acad Sci U S A. 2013;110:E1807\u20131816.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"940_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106\u201318.","journal-title":"Nat Rev Neurol"},{"key":"940_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, Zhou B, Wernig M, Sudhof TC. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion. Cell. 2017;168:427\u2013e441421.","journal-title":"Cell"},{"key":"940_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501\u201318.","journal-title":"Nat Rev Neurol"},{"key":"940_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol neurodegeneration. 2022;17:72.","journal-title":"Mol neurodegeneration"},{"key":"940_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"940_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. Neuron. 2021;109:205\u201321.","journal-title":"Neuron"},{"key":"940_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, Bu G. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 2022;110:1304\u201317.","journal-title":"Neuron"},{"key":"940_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol neurodegeneration. 2019;14:32.","journal-title":"Mol neurodegeneration"},{"key":"940_CR11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"CC Liu","year":"2023","unstructured":"Liu CC, Wang N, Chen Y, Inoue Y, Shue F, Ren Y, Wang M, Qiao W, Ikezu TC, Li Z, et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat Immunol. 2023;24:1854\u201366.","journal-title":"Nat Immunol"},{"key":"940_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-025-00857-6","volume":"20","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang L, Qin C. Alzheimer\u2019s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response. Mol Neurodegener. 2025;20:67.","journal-title":"Mol Neurodegener"},{"key":"940_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-025-00819-y","volume":"20","author":"DR Thal","year":"2025","unstructured":"Thal DR, Poesen K, Vandenberghe R, De Meyer S. Alzheimer\u2019s disease neuropathology and its estimation with fluid and imaging biomarkers. Mol neurodegeneration. 2025;20:33.","journal-title":"Mol neurodegeneration"},{"key":"940_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","volume":"20","author":"AA Belaidi","year":"2025","unstructured":"Belaidi AA, Bush AI, Ayton S. Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities. Mol neurodegeneration. 2025;20:47.","journal-title":"Mol neurodegeneration"},{"key":"940_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","volume":"34","author":"LG Yang","year":"2023","unstructured":"Yang LG, March ZM, Stephenson RA, Narayan PS. Apolipoprotein E in lipid metabolism and neurodegenerative disease. Trends Endocrinol Metab. 2023;34:430\u201345.","journal-title":"Trends Endocrinol Metab"},{"key":"940_CR16","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1038\/s41467-025-60099-4","volume":"16","author":"KB Murphy","year":"2025","unstructured":"Murphy KB, Hu D, Wolfs L, Rohde SK, Fauro GL, Geric I, Mancuso R, De Strooper B, Marzi SJ. The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia xenografted into a mouse model of Alzheimer\u2019s disease. Nat Commun. 2025;16:4883.","journal-title":"Nat Commun"},{"key":"940_CR17","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657\u2013e16741657.","journal-title":"Neuron"},{"key":"940_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-022-00577-1","volume":"17","author":"N Wang","year":"2022","unstructured":"Wang N, Wang M, Jeevaratnam S, Rosenberg C, Ikezu TC, Shue F, Doss SV, Alnobani A, Martens YA, Wren M, et al. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol neurodegeneration. 2022;17:75.","journal-title":"Mol neurodegeneration"},{"key":"940_CR19","doi-asserted-by":"publisher","first-page":"110006","DOI":"10.1016\/j.isci.2024.110006","volume":"27","author":"N Wang","year":"2024","unstructured":"Wang N, Cai L, Pei X, Lin Z, Huang L, Liang C, Wei M, Shao L, Guo T, Huang F, et al. Microglial apolipoprotein E particles contribute to neuronal senescence and synaptotoxicity. iScience. 2024;27:110006.","journal-title":"iScience"},{"key":"940_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2007.04831.x","volume":"103","author":"B Maloney","year":"2007","unstructured":"Maloney B, Ge YW, Alley GM, Lahiri DK. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer\u2019s disease. J Neurochem. 2007;103:1237\u201357.","journal-title":"J Neurochem"},{"key":"940_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","volume":"3","author":"F Liao","year":"2015","unstructured":"Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, Sullivan PM, Holtzman DM. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta Neuropathol Commun. 2015;3:70.","journal-title":"Acta Neuropathol Commun"},{"key":"940_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2002;9:305\u201318.","journal-title":"Neurobiol Dis"},{"key":"940_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","volume":"12","author":"JL Jankowsky","year":"2017","unstructured":"Jankowsky JL, Zheng H. Practical considerations for choosing a mouse model of Alzheimer\u2019s disease. Mol neurodegeneration. 2017;12:89.","journal-title":"Mol neurodegeneration"},{"key":"940_CR24","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem. 1997;272:17972\u201380.","journal-title":"J Biol Chem"},{"key":"940_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","volume":"14","author":"TV Huynh","year":"2019","unstructured":"Huynh TV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, Finn MB, Spellman R, Manis M, Tanzi RE, et al. Lack of hepatic apoE does not influence early Abeta deposition: observations from a new APOE knock-in model. Mol neurodegeneration. 2019;14:37.","journal-title":"Mol neurodegeneration"},{"key":"940_CR26","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"940_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman GE, Schadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 2016;17:483.","journal-title":"BMC Bioinformatics"},{"key":"940_CR28","doi-asserted-by":"publisher","first-page":"9829","DOI":"10.1021\/acscatal.4c01175","volume":"14","author":"T Worakul","year":"2024","unstructured":"Worakul T, Laplaza R, Das S, Wodrich MD, Corminboeuf C. Microkinetic Molecular Volcano Plots for Enhanced Catalyst Selectivity and Activity Predictions. ACS Catal. 2024;14:9829\u201339.","journal-title":"ACS Catal"},{"key":"940_CR29","doi-asserted-by":"publisher","first-page":"706907","DOI":"10.3389\/fgene.2021.706907","volume":"12","author":"CH Gao","year":"2021","unstructured":"Gao CH, Yu G, Cai P. ggVennDiagram: An Intuitive, Easy-to-Use, and Highly Customizable R Package to Generate Venn Diagram. Front Genet. 2021;12:706907.","journal-title":"Front Genet"},{"key":"940_CR30","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139.","journal-title":"Bioinformatics"},{"key":"940_CR31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"940_CR32","doi-asserted-by":"publisher","DOI":"10.3791\/61684","volume-title":"High-throughput and Deep-proteome Profiling by 16-plex Tandem Mass Tag Labeling Coupled with Two-dimensional Chromatography and Mass Spectrometry","author":"Z Wang","year":"2020","unstructured":"Wang Z, Kavdia K, Dey KK, Pagala VR, Kodali K, Liu D, Lee DG, Sun H, Chepyala SR, Cho JH, et al. High-throughput and Deep-proteome Profiling by 16-plex Tandem Mass Tag Labeling Coupled with Two-dimensional Chromatography and Mass Spectrometry. Journal of visualized experiments: JoVE; 2020."},{"key":"940_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes CS, Moggridge S, Muller T, Sorensen PH, Morin GB, Krijgsveld J. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat Protoc. 2019;14:68\u201385.","journal-title":"Nat Protoc"},{"key":"940_CR34","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1074\/mcp.D500009-MCP200","volume":"5","author":"D Cheng","year":"2006","unstructured":"Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM, Xu P, Wijayawardana SR, Hanfelt J, Nakagawa T, et al. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell proteomics: MCP. 2006;5:1158\u201370.","journal-title":"Mol Cell proteomics: MCP"},{"key":"940_CR35","doi-asserted-by":"crossref","unstructured":"Yarbro JM, Shrestha HK, Wang Z, Zhang X, Zaman M, Chu M, Wang X, Yu G, Peng J. Proteomic landscape of Alzheimer\u2019s disease: emerging technologies, advances and insights (2021\u20132025). Molecular neurodegeneration 2025, 20:83.","DOI":"10.1186\/s13024-025-00874-5"},{"key":"940_CR36","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1021\/acs.analchem.6b04415","volume":"89","author":"M Niu","year":"2017","unstructured":"Niu M, Cho JH, Kodali K, Pagala V, High AA, Wang H, Wu Z, Li Y, Bi W, Zhang H, et al. Extensive Peptide Fractionation and y(1) Ion-Based Interference Detection Method for Enabling Accurate Quantification by Isobaric Labeling and Mass Spectrometry. Anal Chem. 2017;89:2956\u201363.","journal-title":"Anal Chem"},{"key":"940_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1172\/JCI2673","volume":"102","author":"PM Sullivan","year":"1998","unstructured":"Sullivan PM, Mezdour H, Quarfordt SH, Maeda N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J Clin Invest. 1998;102:130\u20135.","journal-title":"J Clin Invest"},{"key":"940_CR38","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1172\/JCI6172","volume":"103","author":"C Knouff","year":"1999","unstructured":"Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest. 1999;103:1579\u201386.","journal-title":"J Clin Invest"},{"key":"940_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Abeta accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol neurodegeneration. 2022;17:13.","journal-title":"Mol neurodegeneration"},{"key":"940_CR40","doi-asserted-by":"publisher","first-page":"838436","DOI":"10.3389\/fnagi.2022.838436","volume":"14","author":"KE Foley","year":"2022","unstructured":"Foley KE, Hewes AA, Garceau DT, Kotredes KP, Carter GW, Sasner M, Howell GR. The APOE (epsilon3\/epsilon4) Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice. Front Aging Neurosci. 2022;14:838436.","journal-title":"Front Aging Neurosci"},{"key":"940_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1101\/lm.053588.122","volume":"29","author":"JW McLean","year":"2022","unstructured":"McLean JW, Bhattrai A, Vitali F, Raikes AC, Wiegand JL, Brinton RD. Contributions of sex and genotype to exploratory behavior differences in an aged humanized APOE mouse model of late-onset Alzheimer\u2019s disease. Learn Mem. 2022;29:321\u201331.","journal-title":"Learn Mem"},{"key":"940_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jnc.15665","volume":"163","author":"J Sepulveda","year":"2022","unstructured":"Sepulveda J, Luo N, Nelson M, Ng CAS, Rebeck GW. Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines. J Neurochem. 2022;163:247\u201359.","journal-title":"J Neurochem"},{"key":"940_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuron.2020.02.034","volume":"106","author":"N Zhao","year":"2020","unstructured":"Zhao N, Ren Y, Yamazaki Y, Qiao W, Li F, Felton LM, Mahmoudiandehkordi S, Kueider-Paisley A, Sonoustoun B, Arnold M, et al. Alzheimer\u2019s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways. Neuron. 2020;106:727\u2013e742726.","journal-title":"Neuron"},{"key":"940_CR44","doi-asserted-by":"publisher","first-page":"lqae042","DOI":"10.1093\/nargab\/lqae042","volume":"6","author":"Y Liu","year":"2024","unstructured":"Liu Y. CWGCNA: an R package to perform causal inference from the WGCNA framework. NAR genomics Bioinf. 2024;6:lqae042.","journal-title":"NAR genomics Bioinf"},{"key":"940_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-020-0358-9","volume":"15","author":"T Williams","year":"2020","unstructured":"Williams T, Borchelt DR, Chakrabarty P. Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease. Mol neurodegeneration. 2020;15:8.","journal-title":"Mol neurodegeneration"},{"key":"940_CR46","doi-asserted-by":"publisher","first-page":"134285","DOI":"10.1016\/j.neulet.2019.134285","volume":"707","author":"D Balu","year":"2019","unstructured":"Balu D, Karstens AJ, Loukenas E, Maldonado Weng J, York JM, Valencia-Olvera AC, LaDu MJ. The role of APOE in transgenic mouse models of AD. Neurosci Lett. 2019;707:134285.","journal-title":"Neurosci Lett"},{"key":"940_CR47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/eji.202048546","volume":"50","author":"SA Stifter","year":"2020","unstructured":"Stifter SA, Greter M. STOP floxing around: Specificity and leakiness of inducible Cre\/loxP systems. Eur J Immunol. 2020;50:338\u201341.","journal-title":"Eur J Immunol"},{"key":"940_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s42994-019-00009-7","volume":"1","author":"S Li","year":"2020","unstructured":"Li S, Xia L. Precise gene replacement in plants through CRISPR\/Cas genome editing technology: current status and future perspectives. aBIOTECH. 2020;1:58\u201373.","journal-title":"aBIOTECH"},{"key":"940_CR49","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41467-021-21427-6","volume":"12","author":"S Hans","year":"2021","unstructured":"Hans S, Zoller D, Hammer J, Stucke J, Spiess S, Kesavan G, Kroehne V, Eguiguren JS, Ezhkova D, Petzold A, et al. Cre-Controlled CRISPR mutagenesis provides fast and easy conditional gene inactivation in zebrafish. Nat Commun. 2021;12:1125.","journal-title":"Nat Commun"},{"key":"940_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nbt.2842","volume":"32","author":"JD Sander","year":"2014","unstructured":"Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014;32:347\u201355.","journal-title":"Nat Biotechnol"},{"key":"940_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12529","volume":"45","author":"M Tzioras","year":"2019","unstructured":"Tzioras M, Davies C, Newman A, Jackson R, Spires-Jones T. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2019;45:327\u201346.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"940_CR52","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1002\/alz.13358","volume":"19","author":"MM Dunk","year":"2023","unstructured":"Dunk MM, Li J, Liu S, Casanova R, Chen JC, Espeland MA, Hayden KM, Manson JE, Rapp SR, Shadyab AH, et al. Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2023;19:5742\u201354.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"940_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2013.12.016","volume":"64","author":"LA Johnson","year":"2014","unstructured":"Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis. 2014;64:150\u201362.","journal-title":"Neurobiol Dis"},{"key":"940_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacl.2017.11.003","volume":"12","author":"Y Qi","year":"2018","unstructured":"Qi Y, Liu J, Wang W, Wang M, Zhao F, Sun J, Liu J, Zhao D. Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study. J Clin Lipidol. 2018;12:89\u2013e9882.","journal-title":"J Clin Lipidol"},{"key":"940_CR55","doi-asserted-by":"publisher","first-page":"19778","DOI":"10.1074\/jbc.M100418200","volume":"276","author":"KE Kypreos","year":"2001","unstructured":"Kypreos KE, van Dijk KW, van Der Zee A, Havekes LM, Zannis VI. Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203\u2013299 promotes hepatic very low density lipoprotein-triglyceride secretion. J Biol Chem. 2001;276:19778\u201386.","journal-title":"J Biol Chem"},{"key":"940_CR56","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, Wang C, Park J, Tabor GT, Jiang H, et al. APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread. Cell. 2024;187:428\u2013e445420.","journal-title":"Cell"},{"key":"940_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1538\/expanim.20-0158","volume":"70","author":"K Mekada","year":"2021","unstructured":"Mekada K, Yoshiki A. Substrains matter in phenotyping of C57BL\/6 mice. Exp Anim. 2021;70:145\u201360.","journal-title":"Exp Anim"},{"key":"940_CR58","doi-asserted-by":"publisher","first-page":"e0271651","DOI":"10.1371\/journal.pone.0271651","volume":"17","author":"S Nemoto","year":"2022","unstructured":"Nemoto S, Kubota T, Ohno H. Metabolic differences and differentially expressed genes between C57BL\/6J and C57BL\/6\u00a0N mice substrains. PLoS ONE. 2022;17:e0271651.","journal-title":"PLoS ONE"},{"key":"940_CR59","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.conb.2011.08.002","volume":"21","author":"CD Keene","year":"2011","unstructured":"Keene CD, Cudaback E, Li X, Montine KS, Montine TJ. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer\u2019s disease. Curr Opin Neurobiol. 2011;21:920\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"940_CR60","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/alz.13020","volume":"19","author":"CM Kloske","year":"2023","unstructured":"Kloske CM, Barnum CJ, Batista AF, Bradshaw EM, Brickman AM, Bu G, Dennison J, Gearon MD, Goate AM, Haass C, et al. APOE and immunity: Research highlights. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2023;19:2677\u201396.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"940_CR61","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1038\/s41467-025-60370-8","volume":"16","author":"J Giorgio","year":"2025","unstructured":"Giorgio J, Jonson C, Wang Y, Yokoyama JS, Wang J, Jagust WJ. Alzheimer\u2019s Disease Neuroimaging I: Variable and interactive effects of Sex, APOE epsilon4 and TREM2 on the deposition of tau in entorhinal and neocortical regions. Nat Commun. 2025;16:5812.","journal-title":"Nat Commun"},{"key":"940_CR62","doi-asserted-by":"crossref","unstructured":"Gamache J, Yun Y, Chiba-Falek O. Sex-dependent effect of APOE on Alzheimer\u2019s disease and other age-related neurodegenerative disorders. Disease models & mechanisms; 2020. p. 13.","DOI":"10.1242\/dmm.045211"},{"key":"940_CR63","doi-asserted-by":"publisher","first-page":"105349","DOI":"10.1016\/j.yhbeh.2023.105349","volume":"151","author":"LR Cortes","year":"2023","unstructured":"Cortes LR, Forger NG. DNA methylation and demethylation shape sexual differentiation of neurochemical phenotype. Horm Behav. 2023;151:105349.","journal-title":"Horm Behav"},{"key":"940_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/15592294.2019.1649528","volume":"15","author":"CD Cisternas","year":"2020","unstructured":"Cisternas CD, Cortes LR, Bruggeman EC, Yao B, Forger NG. Developmental changes and sex differences in DNA methylation and demethylation in hypothalamic regions of the mouse brain. Epigenetics. 2020;15:72\u201384.","journal-title":"Epigenetics"},{"key":"940_CR65","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1093\/brain\/awab160","volume":"144","author":"S Yan","year":"2021","unstructured":"Yan S, Zheng C, Paranjpe MD, Li Y, Li W, Wang X, Benzinger TLS, Lu J, Zhou Y. Sex modifies APOE epsilon4 dose effect on brain tau deposition in cognitively impaired individuals. Brain. 2021;144:3201\u201311.","journal-title":"Brain"},{"key":"940_CR66","first-page":"e12271","volume":"14","author":"KK Petersen","year":"2022","unstructured":"Petersen KK, Grober E, Lipton RB, Sperling RA, Buckley RF, Aisen PS, Ezzati A. Impact of sex and APOE epsilon4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adults. Alzheimer\u2019s Dement. 2022;14:e12271.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"Suppl 9","key":"940_CR67","first-page":"S49","volume":"19","author":"S Nemes","year":"2023","unstructured":"Nemes S, Logan PE, Manchella MK, Mundada NS, La Joie R, Polsinelli AJ, Hammers DB, Koeppe RA, Foroud TM, Nudelman KN, et al. Sex and APOE epsilon4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2023;19(Suppl 9):S49\u201363.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"940_CR68","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41467-020-14959-w","volume":"11","author":"M Arnold","year":"2020","unstructured":"Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, MahmoudianDehkordi S, Louie G, Moseley MA, Thompson JW, et al. Sex and APOE epsilon4 genotype modify the Alzheimer\u2019s disease serum metabolome. Nat Commun. 2020;11:1148.","journal-title":"Nat Commun"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00940-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:44:21Z","timestamp":1781642661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00940-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Mayo Clinic Institutional Animal Care and Use Committee (IACUC) and followed NIH guidelines for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the contents of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"G.B. consults for SciNeuro Pharmaceuticals. G.B. is a member of the advisory board of Neuron, an associate editor for Science Advances, and the editor-in-chief of Molecular Neurodegeneration. C.C.L. is an employee and Director at Simcere of America. D.M.H. is an inventor on a patent licensed by Washington University to C2N Diagnostics on the therapeutic use of anti-tau antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H is on the scientific advisory boards of C2N Diagnostics, Denali, Genentech, Cajal Therapeutics, Acta, and Switch and consults for Pfizer, Roche, and Annexon. D.M.H serves on the advisory board of Cell and Neuron and is on the editorial board of Annals of Neurology, Molecular Neurodegeneration, and Science Translational Medicine.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}